Myths vs facts: Östradiol and Langlebigkeit

The claim that estradiol alone extends lifespan is a myth. The evidence is nuanced. Estradiol, the primary estrogen, shows protective associations in observational studies for cardiovascular health, bone density, and cognitive function—all contributors to healthy aging. However, randomized controlled trials (e.g., the Women's Health Initiative) yield mixed results: hormone replacement therapy (HRT) with estradiol can increase risks of breast cancer, thrombosis, and stroke, especially in older women or with prolonged use. The net effect on all-cause mortality is not clear. Genetic variants in estrogen receptors (ESR1, ESR2) modulate individual responses, and MyBody-X tests may analyze such markers, but their predictive power for longevity is limited. Fact: moderate estradiol levels appear beneficial, but extremes are not. Hormonal decisions require medical supervision. Evidence for direct lifespan extension is weak; the focus should be on healthspan improvement with careful risk-benefit assessment.